Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...
A report into recurrent prostate cancer by ... to androgen ablation from initial responsiveness. Thus, the broader application of early microenvironment-targeting therapy will rely on the ...
With the publication of the long-term results of two randomized screening trials and updates to screening guidelines from many organizations, the past 2 years have been eventful in the field of ...
Table I displays demographic, disease and treatment ... at least 90% of the prostate received) were averaged for a random sample of 25 patients each in the androgen ablation and no-androgen ...
But in others, the cancer can be aggressive and deadly. Prostate cancer that's detected early has the best chance for successful treatment. One in eight men will get prostate cancer at some point ...
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system ... function-preserving treatment for men with prostate tumors,” AngioDynamics’ president ...
Prostate cancer is the second leading cause of ... Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation, Journal of Urology (2024). DOI: 10.1097/JU.
The high-voltage pulses in IRE create permanent nanopores in membranes of cancer cells, inducing apoptotic-like cellular death in the target tissue. NanoKnife treatment involves no knives ...
The presentation will be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section. About Profound Medical Corp. Profound is a ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving ...
European Union: The NanoKnife System is indicated for the ablation of prostate ... Focal minimally invasive treatment in localized prostate cancer: comprehensive review of different possible ...